139 related articles for article (PubMed ID: 17415588)
1. The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer.
Zogopoulos G; Rothenmund H; Eppel A; Ash C; Akbari MR; Hedley D; Narod SA; Gallinger S
Hum Genet; 2007 Jun; 121(5):635-7. PubMed ID: 17415588
[TBL] [Abstract][Full Text] [Related]
2. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.
Pogue-Geile KL; Chen R; Bronner MP; Crnogorac-Jurcevic T; Moyes KW; Dowen S; Otey CA; Crispin DA; George RD; Whitcomb DC; Brentnall TA
PLoS Med; 2006 Dec; 3(12):e516. PubMed ID: 17194196
[TBL] [Abstract][Full Text] [Related]
3. Absence of deleterious palladin mutations in patients with familial pancreatic cancer.
Klein AP; Borges M; Griffith M; Brune K; Hong SM; Omura N; Hruban RH; Goggins M
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1328-30. PubMed ID: 19336541
[TBL] [Abstract][Full Text] [Related]
4. Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells.
Salaria SN; Illei P; Sharma R; Walter KM; Klein AP; Eshleman JR; Maitra A; Schulick R; Winter J; Ouellette MM; Goggins M; Hruban R
Cancer Biol Ther; 2007 Mar; 6(3):324-8. PubMed ID: 17404500
[TBL] [Abstract][Full Text] [Related]
5. [Familial pancreatic cancer and the palladin gene: a new look at cancer mechanisms].
Gilgenkrantz S
Med Sci (Paris); 2007 Mar; 23(3):232-4. PubMed ID: 17349274
[No Abstract] [Full Text] [Related]
6. Palladin mutation causes familial pancreatic cancer: absence in European families.
Slater E; Amrillaeva V; Fendrich V; Bartsch D; Earl J; Vitone LJ; Neoptolemos JP; Greenhalf W
PLoS Med; 2007 Apr; 4(4):e164. PubMed ID: 17455999
[No Abstract] [Full Text] [Related]
7. Familial pancreatic-cancer gene found.
Bradbury J
Lancet Oncol; 2007 Jan; 8(1):14. PubMed ID: 17348120
[No Abstract] [Full Text] [Related]
8. Palladin expression is a conserved characteristic of the desmoplastic tumor microenvironment and contributes to altered gene expression.
Cannon AR; Owen MK; Guerrero MS; Kerber ML; Goicoechea SM; Hemstreet KC; Klazynski B; Hollyfield J; Chang EH; Hwang RF; Otey CA; Kim HJ
Cytoskeleton (Hoboken); 2015 Aug; 72(8):402-11. PubMed ID: 26333695
[TBL] [Abstract][Full Text] [Related]
9. Isoform-specific upregulation of palladin in human and murine pancreas tumors.
Goicoechea SM; Bednarski B; Stack C; Cowan DW; Volmar K; Thorne L; Cukierman E; Rustgi AK; Brentnall T; Hwang RF; McCulloch CA; Yeh JJ; Bentrem DJ; Hochwald SN; Hingorani SR; Kim HJ; Otey CA
PLoS One; 2010 Apr; 5(4):e10347. PubMed ID: 20436683
[TBL] [Abstract][Full Text] [Related]
10. Familial pancreatic cancer: hope can become truth.
Pezzilli R; Fantini L
JOP; 2007 Jan; 8(1):64-6. PubMed ID: 17228136
[No Abstract] [Full Text] [Related]
11. Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer.
Real FX; Malats N; Lesca G; Porta M; Chopin S; Lenoir GM; Sinilnikova O;
Gut; 2002 May; 50(5):653-7. PubMed ID: 11950811
[TBL] [Abstract][Full Text] [Related]
12. Palladin, an actin-associated protein, is required for adherens junction formation and intercellular adhesion in HCT116 colorectal cancer cells.
Tay PN; Tan P; Lan Y; Leung CH; Laban M; Tan TC; Ni H; Manikandan J; Rashid SB; Yan B; Yap CT; Lim LH; Lim YC; Hooi SC
Int J Oncol; 2010 Oct; 37(4):909-26. PubMed ID: 20811713
[TBL] [Abstract][Full Text] [Related]
13. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
[TBL] [Abstract][Full Text] [Related]
14. Twist1-induced activation of human fibroblasts promotes matrix stiffness by upregulating palladin and collagen α1(VI).
García-Palmero I; Torres S; Bartolomé RA; Peláez-García A; Larriba MJ; Lopez-Lucendo M; Peña C; Escudero-Paniagua B; Muñoz A; Casal JI
Oncogene; 2016 Oct; 35(40):5224-5236. PubMed ID: 26973246
[TBL] [Abstract][Full Text] [Related]
15. Identification of palladin isoforms and characterization of an isoform-specific interaction between Lasp-1 and palladin.
Rachlin AS; Otey CA
J Cell Sci; 2006 Mar; 119(Pt 6):995-1004. PubMed ID: 16492705
[TBL] [Abstract][Full Text] [Related]
16. Genetic testing by cancer site: pancreas.
Axilbund JE; Wiley EA
Cancer J; 2012; 18(4):350-4. PubMed ID: 22846737
[TBL] [Abstract][Full Text] [Related]
17. Palladin is a marker of liver metastasis in primary pancreatic endocrine carcinomas.
Henderson-Jackson EB; Helm J; Strosberg J; Nasir NA; Yeatman TJ; Kvols LK; Coppola D; Nasir A
Anticancer Res; 2011 Sep; 31(9):2957-62. PubMed ID: 21868544
[TBL] [Abstract][Full Text] [Related]
18. Hereditary pancreatic cancer: a clinical perspective.
Greer JB; Lynch HT; Brand RE
Best Pract Res Clin Gastroenterol; 2009; 23(2):159-70. PubMed ID: 19414143
[TBL] [Abstract][Full Text] [Related]
19. The Role of Palladin in Podocytes.
Artelt N; Ludwig TA; Rogge H; Kavvadas P; Siegerist F; Blumenthal A; van den Brandt J; Otey CA; Bang ML; Amann K; Chadjichristos CE; Chatziantoniou C; Endlich K; Endlich N
J Am Soc Nephrol; 2018 Jun; 29(6):1662-1678. PubMed ID: 29720549
[No Abstract] [Full Text] [Related]
20. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.
Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP
Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
